Wed, Aug 20, 2014, 8:52 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fribon fribon May 1, 1998 10:17 PM Flag

    huge increase in short interest

    I agree that bad news regarding Vx-478 will crush
    Vertex, short term. However, I think that the predictive
    value of Phase II success for Phase III success with
    the Protease Inhibitors has been very good for other
    companies.

    I think the slow pace of development and
    announcements has caused individuals and mutual fund types to
    search for greener pastures (given the precariousness of
    the market and the fact that anything can happen (and
    will) in Biotech)

    Another potential surprise
    with Vertex is VX-710 (in pivotal Phase II's).
    Basically they need to announce (with Biochem Pharma)
    whether this MDR Cancer drug is going into Phase III or
    into the waste basket (like their Hemoglobbin
    disorders program). According to some research I read these
    data should have been out in early 1998. If this drug
    moves on, I think their Cancer Program could get
    block-buster-euphoria status. If it fails, tighten your belt a notch.


    Regards,

    Fribon

 
VRTX
91.30-0.62(-0.67%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.